Generation of Leukaemia-Derived Dendritic Cells (DC(leu)) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations

Dendritic cells (DC) and leukaemia derived DC (DC(leu)) are potent stimulators of anti-leukaemic activity in acute myeloid leukaemia (AML) and can be generated from mononuclear cells in vitro following standard DC/DC(leu)-generating protocols. With respect to future clinical applications though, DC/...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwepcke, Christoph, Klauer, Lara Kristina, Deen, Diana, Amberger, Daniel Christoph, Fischer, Zuzana, Doraneh-Gard, Fatemeh, Gunsilius, Carina, Hirn-Lopez, Annika, Kroell, Tanja, Tischer, Johanna, Weinmann, Melanie, Werner, Jan-Ole, Rank, Andreas, Schmid, Christoph, Schmetzer, Helga Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368668/
https://www.ncbi.nlm.nih.gov/pubmed/35955486
http://dx.doi.org/10.3390/ijms23158333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368668/
https://www.ncbi.nlm.nih.gov/pubmed/35955486
http://dx.doi.org/10.3390/ijms23158333

Ejemplares similares